Want to see DE:ACT0 full AI Analyst Report?
Top Page
AlzChem Group AG
(XETRA:ACT0)
Select Model
Select Model
Rating:69Neutral
Price Target:
€169.00
▲(4.19% Upside)
Action:Reiterated
Date:08/04/26
The score is supported primarily by solid financial performance and a constructive earnings outlook (reaffirmed FY2026 guidance, strong Specialty Chemicals margins, and expansion progress). Offsetting factors are weaker technicals (price below key moving averages with negative MACD) and some fundamental risks around free-cash-flow volatility and higher recent debt, while valuation is only moderately attractive (P/E ~23 and a modest ~1.36% yield).
Positive Factors
Specialty Chemicals growth and margins
The specialty portfolio is becoming a larger share of sales while delivering strong margins, supported by favorable mix, higher volumes and high utilization. This mix shift can improve earnings quality and provide resilience beyond cyclical basic chemicals.
Negative Factors
Volatile free cash flow and higher debt
The gap between operating cash flow and free cash flow indicates substantial investment or working-capital demands. Combined with higher debt, this can reduce financial flexibility and increase sensitivity to weaker margins or delayed project returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Specialty Chemicals growth and margins
The specialty portfolio is becoming a larger share of sales while delivering strong margins, supported by favorable mix, higher volumes and high utilization. This mix shift can improve earnings quality and provide resilience beyond cyclical basic chemicals.
Read all positive factors
AlzChem Group AG (ACT0) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€1.64B
Dividend Yield1.27%
Average Volume (3M)19.69K
Price to Earnings (P/E)23.9
Beta (1Y)0.56
Revenue GrowthN/A
EPS GrowthN/A
CountryDE
Employees1,765
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)6.70
Shares Outstanding10,176,335
10 Day Avg. Volume15,450
30 Day Avg. Volume19,689
Financial Highlights & Ratios
PEG Ratio1.35
Price to Book (P/B)6.11
Price to Sales (P/S)2.79
P/FCF Ratio39.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€216.25Price Target Upside33.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)6.52
Revenue Forecast (FY)€609.49M
AlzChem Group AG Business Overview & Revenue Model
Company Description
Alzchem Group AG engages in the provision of development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment...
How the Company Makes Money
AlzChem makes money primarily by producing and selling specialty chemical products and chemical intermediates to business customers. Revenue is generated through (1) sales of specialty chemicals and intermediates—where customers pay per delivered ...
AlzChem Group AG Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
61
Positive
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
AlzChem Group AG Technical Analysis
Positive
162.20
Price Trends
164.41
Positive
169.16
Negative
163.73
Positive
Market Momentum
-0.47
Negative
55.99
Neutral
34.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:ACT0, the sentiment is Positive. The current price of 162.2 is below the 20-day moving average (MA) of 162.71, below the 50-day MA of 164.41, and below the 200-day MA of 163.73, indicating a bullish trend. The MACD of -0.47 indicates Negative momentum. The RSI at 55.99 is Neutral, neither overbought nor oversold. The STOCH value of 34.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:ACT0.
AlzChem Group AG Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | €5.03B | 15.58 | 17.00% | 3.48% | 5.53% | 17.05% | |
69 Neutral | €1.64B | 23.85 | 26.12% | 1.27% | ― | ― | |
64 Neutral | €8.18B | 66.94 | 1.49% | 5.78% | -4.03% | -71.46% | |
62 Neutral | €8.78B | 23.79 | 8.30% | 3.17% | -5.28% | -13.76% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | €4.31B | -9.73 | -11.14% | 2.88% | ― | ― | |
43 Neutral | €1.19B | -1.73 | -18.62% | 0.75% | -9.81% | -305.46% |
* Basic Materials Sector Average
DE:ACT0
AlzChem Group AG
165.64
25.26
18.00%
DE:BNR
Brenntag AG
59.94
10.49
21.22%
DE:EVK
Evonik
17.31
2.69
18.38%
DE:FPE
Fuchs Petrolub
35.10
5.70
19.40%
DE:LXS
LANXESS
13.41
-9.12
-40.48%
DE:WCH
Wacker Chemie AG
85.90
22.65
35.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.